JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266559

Human KXD1 (C19orf50) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

KXD1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human KXD1 (C19orf50) knockout HEK-293T cell line (AB266559)
  • Sanger seq

Unknown

Sanger Sequencing - Human KXD1 (C19orf50) knockout HEK-293T cell line (AB266559)

Homozygous : 1 bp insertion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266559-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266559-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266559 Human KXD1 (C19orf50) knockout HEK-293T cell line", "number":"AB266559-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266559-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266559 Human KXD1 (C19orf50) knockout HEK-293T cell line", "number":"AB266559-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266559-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266559-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266559 Human KXD1 (C19orf50) knockout HEK-293T cell line", "number":"AB266559-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266559-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266559 Human KXD1 (C19orf50) knockout HEK-293T cell line", "number":"AB266559-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
KXD1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C19orf50 also known as Chromosome 19 Open Reading Frame 50 is a protein that has a molecular weight of approximately 17 kDa. The protein expresses in various tissues throughout the body indicating a broad role within cellular activities. Though its exact mechanical function isn't fully determined it may interact with other proteins due to its expression levels across different systems.
Biological function summary

Proteins associated with C19orf50 engage in cellular development and maintenance. Evidence suggests it acts as part of a protein complex influencing key processes within cells. Its function may intersect with regulatory mechanisms affecting cellular growth and differentiation.

Pathways

Cellular processes involving C19orf50 are linked with cellular signal transduction and metabolic pathways. The protein potentially interacts with key players in these pathways such as mTOR signaling. This connection aids in modulating cellular energy balance with influences observed alongside proteins like AMPK which play a role in energy homeostasis and cellular response to stress.

C19orf50's role involves pathogeneses related to metabolic dysfunction and proliferative disorders. In the context of type 2 diabetes evidence suggests a possible interaction with insulin signaling proteins contributing to impaired glucose metabolism. Additionally research implicates its regulatory influence in some cancers possibly through modulation of pathways involving tumor suppressor proteins like p53.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com